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Table. Outcomes by degree of kidney disease
Complications
Moderate kidney disease, % Severe kidney disease, %
OP (n ¼ 2371) EP (n ¼ 1446) P OP (n ¼ 311) EP (n ¼ 185) P
Mortality 1.6 0.7 .01 4.5 0 .003
Worsening renal function 1.1 0.4 .01 4.2 1.1 .05
Cardiac events 2.9 1.2 .001 8.0 2.7 .01
Respiratory events 2.8 1.1 .0004 6.1 1.1 .007
Composite outcome 5.8 2.1 <.0001 14.8 3.8 .0001
EP, Endovascular procedure; OP, open procedure.
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Volume 60, Number 3 Abstracts 815hypertension (89.9% vs 90.4%, P ¼ .61). OPs were associated with higher
mortality rates (1.9% vs 0.6%, P ¼ .0004), postoperative worsening of
renal function (1.4% vs 0.4%, P ¼ .002), cardiac events (3.5% vs 1.4%,
P < .0001), respiratory complications (3.2% vs 1.1%, P < .0001), and
combined outcomes (6.8% vs 2.3%, P < .0001). The Table reports results
for stratiﬁed analyses. Signiﬁcantly worse outcomes with OP vs EP tech-
niques persisted in multivariate logistic regression models adjusted for
group differences.
Conclusions: In patients with moderate or severe kidney disease,
endovascular revascularization is associated with lower mortality and
reduced postoperative complications compared with open revascularization.
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Aneurysmal Degeneration of Medically-Managed Acute Type B Aortic
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Objectives: Patients with uncomplicated type B aortic dissections
who are managed medically are at risk of aneurysmal degeneration over
time. However, there is hope that improvement in antihypertensive medica-
tions and stricter blood pressure control will halt this process. The goal of
this study was to determine the rate of aneurysmal degeneration in a
contemporary cohort of patients with medically treated type B dissection.
Methods: All patients with acute uncomplicated type B aortic dissec-
tion who were initially managed medically between March 1999 and March
2011 and had at least two separate axial imaging studies were included.
Maximum aortic growth was calculated by comparing the initial imaging
study with the most current scan or imaging obtained just before any
aortic-related intervention. Predictors of aortic aneurysmal degeneration
were determined using Cox proportional hazards models.
Results: A total of 200 patients (61% male) with medically managed
acute type B dissections receiving multiple imaging studies were identiﬁed.
Average age was 63.4 years and 75.5% had a history of hypertension. Mean
follow-up was 5.3 years (range, 0.1-14.7 years). Mean time between initial
and ﬁnal imaging studies was 3.2 years (range, 0.1-12.9 years). At 5 years,
only 51%were free from aortic growth. Fifty-six patients (28%) required oper-
ative intervention (50 open, 6 endovascular repair) for aneurysmal degenera-
tion, and the actuarial 5-year freedom from intervention was 76%. Mean rate
of aneurysmal degeneration was 24.7 mm/y. Excluding early rapid degener-
ation requiring intervention within the ﬁrst 2 weeks (5 patients [2.5%]), the
mean rate of aneurysmal degenerationwas 12.3mm/y for themaximal lumen
diameter, 3.8 mm/y for the true lumen diameter, and 8.6 mm/y for the false
lumen diameter. Only presenting size >3.5 cm was predictive of future
growth (odds ratio, 2.95; 95% conﬁdence interval, 1.64-5.32; P < .001).
Conclusions: Althoughmedical management of uncomplicated acute,
type B aortic dissections remains the standard of care, a signiﬁcant number of
patients will require operative intervention for aneurysmal degeneration at 5
years. An initial aortic diameter >3.5 cm is predictive of future growth.
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Fenestrated Endovascular Repair of Abdominal Aortic Aneurysms Is
Associated With Comparable Early Morbidity and Mortality to
Infrarenal EVAR>
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Objectives: Previous studies have found an increase in complication rates
after open repair of complex abdominal aortic aneurysms (AAAs) compared
with infrarenal AAAs, with some reporting increased mortality as well. Little is
known about the complication rates of complex fenestrated endovascular aneu-
rysmrepair (FEVAR)comparedwith standard infrarenalEVAR.Thegoalof this
study was to compare complication rates of FEVAR vs EVAR of AAAs.
Methods: The American College of Surgeons National Surgical Qual-
ity Improvement Program database from 2005 to 2012 was queried for
AAAs (International Classiﬁcation of Diseases, 9th edition, 441.4). Patients
were stratiﬁed according to procedure (FEVAR vs EVAR). A bivariate anal-
ysis was done to assess preoperative and intraoperative risk factors for post-
operative 30-day outcomes. Multivariable logistic regression was conducted
to identify independent associations.
Results: A total of 458 patients underwent FEVARand 19,060patients
underwent EVAR for AAA. Patients undergoingFEVARwere older (P¼ .02)
and less likely to have a bleeding disorder (P¼ .046). The groups were other-
wise matched for comorbidities. FEVAR was associated with increased oper-
ative time (182 vs 153 minutes, P < .001) and postoperative length of stay
(3.3 vs 2.8 days, P¼ .03). There was a statistically signiﬁcant increase in post-
operative transfusions (15.3% vs 6.1%, P< .001) and trends toward increased
cardiac complications (2.2% vs 1.3%,P¼ .09) and theneed for dialysis (1.5% vs
0.8%, P ¼ .08) in the FEVAR group. Mortality (2.4% vs 1.5%, P ¼ .12) and
other complication rates were similar. On multivariable analysis, FEVAR
remained independently associated with the need for postoperative transfu-
sions (odds ratio, 2.48; 95% conﬁdence interval, 1.87-3.28; P < .001).
Conclusions: Unlike open repair, FEVAR and EVAR for AAA have
similar outcomes with no difference in mortality. Although FEVAR was
associated with increased postoperative transfusions, this was not associated
with an increased rate of return to the operating room or mortality. Thus,
FEVAR can be performed safely outside of the clinical trial setting with min-
imal increased risks compared with infrarenal EVAR.
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Objectives: This study evaluated the impact of gender on early and
late outcomes of peripheral vascular interventions (PVIs) for intermittent
claudication (IC) and critical limb ischemia (CLI).
Methods: We reviewed 3338 patients (1316 [39%] women) under-
going PVIs for IC (1892 [57%]) or CLI (1446 [43%]) in the Vascular Study>Eastern Vascular Society
yNew England Society for Vascular Surgery
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analysis evaluated relationships between gender and primary outcomes of
major amputation and overall survival at 1 year.
Results: Indications for PVI included IC in 719 (22%) vs 1173 (35%)
and CLI in 597 (18%) vs 849 (25%), women and men, respectively. Women
were older (69 vs 66 mean years, P< .00001) with less diabetes (43% vs 49%,
P¼ .01), renal insufﬁciency (4.6% vs 7.3%, P¼ .0029), coronary artery disease
(28% vs 35%, P < .00001), smoking (76% vs 86%, P ¼ .01), and statin use
(60% vs 64%, P ¼ .0058). Women were more likely to present with CLI
(45% vs 42%, P ¼ .0028) and ambulate with assistance (16% vs 12%, P ¼
.0016). Technical success (95% vs 94%, P ¼ .11), vascular injury (1.3% vs
1.0%, P ¼ .82), and embolization (1.6% vs 1.3%, P ¼ .46) were similar,
with higher rates of hematoma (7.1% vs 3.4%, P < .0001) and access-site oc-
clusion (0.91% vs 0.24%, P ¼ .0085) in women. There were no differences in
1-year major amputation rates between men and women for patients with IC
or CLI. Survival at 1 year was similar between women and men with IC (95%
vs 96%, P ¼ .19) and CLI (77% vs 79%, P ¼ .35). The model demonstrated
moderate discriminative ability (receiver-operating characteristic curve,
0.81; Fig, Table).
Conclusions: Procedural morbidity was modestly greater in women,
with higher rates of hematoma and access-site occlusion. We found no
gender disparity in amputation rates or overall survival in patients undergo-
ing PVIs for claudication or CLI. Further study is necessary to determine if
gender should play a role in selection of therapy for patients harboring lower
extremity occlusive disease.Table. Predictors of overall survival after peripheral vascular intervention
Variable OR 95% CI P
Age 1.04 1.02-1.06 .0001
Claudication 0.41 0.30-0.57 .0001
Congestive heart failure 2.32 1.70-3.18 .0001
COPD 1.57 1.15-2.13 .004
Nonambulatory pre-op 2.83 1.57-5.10 .001
b-Blocker use 1.42 1.03-1.96 .034
CI, Conﬁdence interval; COPD, chronic obstructive pulmonary disease;
OR, odds ratio.
Fig. Kaplan-Meier survival estimates.
Table. Odds ratios for the association of risk factors with phenotypes of
vascular disease in men and women
Risk
factor
Age >
70 years
Hyper-
tension
Hyper-
lipidemia
+Smoking
history Diabetes
Obesity
(BMI
>30 kg/m2)
AAA
Men 3.08 1.44 1.47 2.39 0.94 NS on
univariate
analysis
Women 1.95 1.28 1.27 1.65 1.19 NS on
univariate
analysis
CS
Men 2.79 1.87 1.66 1.67 1.55 NS on
univariate
analysis
Women 2.30 1.99 1.60 1.79 1.64 NS on
univariate
analysis
PAD
Men 2.61 1.75 1.16 1.95 1.73 0.84
Women 2.27 1.62 1.08 1.70 1.52 1.10
AAA, Abdominal aortic aneurysm; BMI, body mass index; CS, carotid
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Objectives: Most reported studies on atherosclerosis involve a pre-
dominance of men. There is a lack of information into the speciﬁc role of>Eastern Vascular Societyatherosclerotic risk factors and their effects on the development of periph-
eral vascular diseases in women. The goal of this study was to analyze the
association of known risk factors and the prevalence peripheral arterial dis-
ease (PAD), carotid stenosis (CS), and abdominal aortic aneurysm (AAA)
in men and women.
Methods: Data of 3,696,778 individuals who underwent vascular
screening examinations were used. PAD was deﬁned as an ankle-brachial in-
dex of #0.9, CS as stenosis of $50% of the left or right internal carotid ar-
tery, and AAA as an aortic diameter of $3 cm. Multivariate analyses were
used to determine odds ratios for the effect of each individual risk factor
on each phenotype of vascular disease in men and women.
Results: Overall, AAA was noted in 1.8% of men (n ¼ 1,392,169) and
in 0.3% of women (n ¼ 2,304,609). Respective rates of PAD and CS were
3.2% and 4.4% in men, and 3.8% and 3.5% in women. Odds ratios for the
association of risk factors with vascular disease phenotypes in men and
women are reported in the Table. Increased age and a positive smoking his-
tory were more signiﬁcantly associated with AAA in men than in women,
and diabetes was mildly protective against AAA in men but not in women.
Increased age was more signiﬁcantly associated with CS in men than in
women, whereas hypertension, diabetes, and a positive smoking history
were more signiﬁcant risk factors in women. Increased age, a positive smok-
ing history, and diabetes were more signiﬁcant risk factors for PAD in men;
obesity (body mass index >30 kg/m2) conferred a mildly protective associ-
ation with PAD in men but was a positive risk factor for the prevalence of
PAD in women.
Conclusions: Our study suggests that atherosclerotic risk factors may
not have the same effects on vascular diseases in men and women. Increased
age appears to be a more signiﬁcant risk factor in men. Notably, diabetes
was inversely associated with AAA in men but not in women, and obesity
was mildly protective against PAD in men but not in women. Our results
suggest that atherosclerotic risk factor reduction strategies may need to be
sex-speciﬁc.Disclosures: C. B. Rockman: Nothing to disclose; Y. Guo: Nothing to
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Objectives: In 2009, the Society for Vascular Surgery established
objective performance goals (OPG) for lower extremity bypass (LEB) in pa-
tients with critical limb ischemia (CLI) based on pooled data from previ-
ously performed prospective studies. Patients with a prosthetic conduit
and end-stage renal disease (ESRD) were excluded. Patients within theyNew England Society for Vascular Surgery
